Korea Kolmar Co Ltd - Strategy, SWOT and Corporate Finance Report

Published: February 2019
Publisher: MarketLine
Product ref: 307048
Pages: 25
Format: PDF
Delivery: By product vendor

Report description

Summary
Korea Kolmar Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.

Key Findings
• Detailed information on Korea Kolmar Co Ltd required for business and competitor intelligence needs.
• A study of the major internal and external factors affecting Korea Kolmar Co Ltd in the form of a SWOT analysis.
• An in-depth view of the business model of Korea Kolmar Co Ltd including a breakdown and examination of key business segments.
• Intelligence on Korea Kolmar Co Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
• News about Korea Kolmar Co Ltd, such as business expansion, restructuring, and contract wins.
• Large number of easy-to-grasp charts and graphs that present important data and key trends.

Reasons To Buy
• Gain understanding of Korea Kolmar Co Ltd and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Korea Kolmar Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Korea Kolmar Co Ltd's business structure, strategy and prospects.

Key Highlights
Korea Kolmar Co. Ltd. (Korea Kolmar) is a developer and manufacturer of health and beauty products. It is involved in contract manufacturing of cosmetics and pharmaceuticals products. Its product portfolio includes skin care products, make up products, body and hair care products, perfumes, pharmaceutical and quasi drugs. It also offers specialized medicine and general medicine such as antipyretics, analgesics and endocrine medicine along with health functional foods. The company focuses on the research and development of quasi drugs, sanitizers and tooth paste among others. It operates through four research and development centers and six production facilities in South Korea. Korea Kolmar is headquartered in Seoul, South Korea.